
Ascendis Pharma A/S (NASDAQ:ASND) Q1 2025 Earnings Call Transcript
Ascendis Pharma A/S (NASDAQ:ASND) Q1 2025 Earnings Call Transcript May 1, 2025 Ascendis Pharma A/S misses on earnings expectations. Reported EPS is $-1.79348 EPS, expectations were $-1.56. Operator: Ladies and gentlemen, thank you for standing by …